American Society of Hirudotherapy

[Hirudotherapy in the treatment of peripheral cochleovestibular disorders of vascular origin]

Research article published in Vestnik otorinolaringologii (2009)

Last Updated: March 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Clinical TrialsMorozova S, Aksenova O · Vestnik otorinolaringologii, 2009

Abstract

Basic therapy of peripheral cochleovestibular disorders of vascular origin consists of the rational combination of medicamentous and non-medicamentous treatments that collectively ensure positive clinical results. The use of hirudotherapy for the management of peripheral cochleovestibular disorders resulted in the substantial decrease of ear noise and the maintenance of the tendency toward further improvement of cochlear and vestibular functions.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal Article
Indexed MeSH termsAdultAgedAudiometry, Evoked ResponseBrachial ArteryCerebral AngiographyCochlear DiseasesDiagnosis, DifferentialFemaleFollow-Up StudiesHumansLeechingMale

Summary

Basic therapy of peripheral cochleovestibular disorders of vascular origin consists of the rational combination of medicamentous and non-medicamentous treatments that collectively ensure positive clinical results.

Why This Matters for Hirudotherapy

Contributes clinical evidence for the therapeutic application of leech therapy.

Citation

[Hirudotherapy in the treatment of peripheral cochleovestibular disorders of vascular origin].

Morozova S, Aksenova O · Vestnik otorinolaringologii, 2009

Added to ASH library: March 18, 2026 · Site last updated: March 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.

[Hirudotherapy in the treatment of peripheral cochleovestibular disorders of vascular origin] | ASH